BioCryst To Present Peramivir Trial Results For The Treatment Of Influenza At The ICAAC 2014 Meeting
September 02, 2014 at 06:53 AM EDT
BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced the presentation of trial results related to intravenous (I.V.) peramivir ...